Global Vinpocetine Market 2017 - Gedeon Richter, Runhong, Sun Pharma, WZT, PUDE, Welman, ZhiTong

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Vinpocetine Market 2017 Forecast to 2022

Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis.

Request For Sample Report @ https://www.fiormarkets.com/report-detail/105850/request-sample

Scope of the Report:
This report focuses on the Vinpocetine in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Gedeon Richter
Runhong
Sun Pharma
WZT
PUDE
Welman
ZhiTong
Liaoning Zhiying
COVEX
Northeast Pharma
Micro Labs

Access Full Report With TOC @ http://www.fiormarkets.com/report/global-north-america-europe-and-asia-pacific-south-america-105850.html

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Tablet
Injection

Market Segment by Applications, can be divided into
Household
Hospital

There are 15 Chapters to deeply display the global Vinpocetine market.

Contact Us
Mark Stone
Sales Manager
Phone: (201) 465-4211
Email: [email protected]
Web: www.fiormarkets.com